ConductScience.org, home

Paper19711978

Platinum drug distribution in cancer cells and tumors.

Klein AV and 1 other. Chem Rev, 2009. Cited by 223 papers, by iCite.

Cite this record

ConductScience Library. Platinum drug distribution in cancer cells and tumors. Papers, record 19711978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19711978

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platinum drug distribution in cancer cells and tumors.
PubMed
Journal
Chem Rev
PubMed
Year
2009
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
223
iCite
Relative citation ratio, by iCite
6.4
iCite
Revised in PubMed
2022-11-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klein AVAlice V
2Hambley TWTrevor W

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
PlatinumMajor topic
Animals
Humans
Models, Biological

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.

PMIDTitleJournalYearIn PapersSource
41787885Molecular Dynamics Simulation of Passive Diffusion across a Human Breast Cancer Cell Membrane Model. Comparison between Cisplatin and Its Pt(IV) Derivatives.J Chem Inf Model2026https://conductscience.org/library/papers/41787885PubMed
40625908Recent progress in stimuli-activable metallo-prodrugs for cancer therapy.Smart Mol2024https://conductscience.org/library/papers/40625908PubMed
40489661Studying Noncovalent Interactions in Molecular Systems with Machine Learning.Chem Rev2025https://conductscience.org/library/papers/40489661PubMed
40315445Protoporphyrin IX-Derived Ruthenium(II) Complexes for Photodynamic Therapy in Gastric Cancer Cells.Inorg Chem2025https://conductscience.org/library/papers/40315445PubMed
39878587Exploring the Structure-Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) Prodrugs.Inorg Chem2025https://conductscience.org/library/papers/39878587PubMed
39031237An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects.J Fluoresc2025https://conductscience.org/library/papers/39031237PubMed
39025943Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours.Nat Biomed Eng2024https://conductscience.org/library/papers/39025943PubMed
38801468Binding energies and hydrogen bonds effects on DNA-cisplatin interactions: a DFT-xTB study.J Mol Model2024https://conductscience.org/library/papers/38801468PubMed
38613713Synthesis and Characterization of Zn(II) Complex of 4-chloro-2-(((2-phenoxyphenyl)imino)methyl)phenol and its Biological Efficacies: DNA Interaction, ADMET, DFT and Molecular Docking Study.J Fluoresc2025https://conductscience.org/library/papers/38613713PubMed
37687231Oxidation of the Platinum(II) Anticancer Agent [Pt{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide.Molecules2023https://conductscience.org/library/papers/37687231PubMed
37615895Study on the Interactions Between Cisplatin and Cadherin by Fluorescence Spectrometry and Atomic Force Microscopy.J Fluoresc2024https://conductscience.org/library/papers/37615895PubMed
37241854Novel Biotinylated Cu(II)-Phenanthroline Complexes: 2D and 3D Cytotoxic Activity and Mechanistic Insight.Molecules2023https://conductscience.org/library/papers/37241854PubMed
37083254Regium-π Bonds Involving Nucleobases: Theoretical Study and Biological Implications.Inorg Chem2023https://conductscience.org/library/papers/37083254PubMed
36457031Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011-2022 review.J Nanobiotechnology2022https://conductscience.org/library/papers/36457031PubMed
36324675Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy.Front Pharmacol2022https://conductscience.org/library/papers/36324675PubMed
36311834One Stone Two Birds: Redox-Sensitive Colocalized Delivery of Cisplatin and Nitric Oxide through Cascade Reactions.JACS Au2022https://conductscience.org/library/papers/36311834PubMed
36253861The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.J Hematol Oncol2022https://conductscience.org/library/papers/36253861PubMed
36080200Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.Molecules2022https://conductscience.org/library/papers/36080200PubMed
36014491Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation.Molecules2022https://conductscience.org/library/papers/36014491PubMed
35849344LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms.Nucleic Acids Res2022https://conductscience.org/library/papers/35849344PubMed

See all 59 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19711978

GET https://conductscience.org/api/papers/v1/19711978/cited_by?page=2